Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

Clinical trial NCT06548607 · RECRUITING

Trial details

NCT number: NCT06548607
Sponsor: Nanjing Bioheng Biotech Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE (Systemic Lupus)Systemic Sclerosis ANCA Associated Vasculitis Idiopathic Inflammatory Myopathies Sjogren's Syndrome Autoimmune Diseases

Start date: 2024-09-14
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.